Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Lishengpharma(002393) the Revenue is 309.35 M (-14.47%);the EBIT is 21.63 M (+24.61%);the EPS is 0.0838 (-91.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.31B14.47%
----
----
EBIT
0.02B24.61%
----
----
EPS
0.083891.20%
----
----
Upcoming earnings report - Q3 FY2026
Available dateOct 26, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf